Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
410.5 GBX | -1.86% | -0.58% | -6.87% |
Apr. 23 | Corporate results bound the become the next catalyst for markets | |
Apr. 23 | JPMorgan Resumes Rentokil Initial Coverage with Neutral Rating | MT |
Sales 2024 * | 5.53B 6.91B | Sales 2025 * | 5.8B 7.25B | Capitalization | 10.31B 12.9B |
---|---|---|---|---|---|
Net income 2024 * | 399M 499M | Net income 2025 * | 522M 653M | EV / Sales 2024 * | 2.41 x |
Net Debt 2024 * | 3.01B 3.76B | Net Debt 2025 * | 2.68B 3.35B | EV / Sales 2025 * | 2.24 x |
P/E ratio 2024 * |
26.2
x | P/E ratio 2025 * |
20
x | Employees | 62,931 |
Yield 2024 * |
2.21% | Yield 2025 * |
2.49% | Free-Float | 98.9% |
Latest transcript on Rentokil Initial plc
1 day | -1.86% | ||
1 week | -0.58% | ||
Current month | -12.97% | ||
1 month | -11.49% | ||
3 months | +4.59% | ||
6 months | -9.70% | ||
Current year | -6.87% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Ransom
CEO | Chief Executive Officer | 60 | 08-04-30 |
Director of Finance/CFO | - | 06-12-31 | |
Brian Webb
COO | Chief Operating Officer | - | 19-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
David J. Frear
BRD | Director/Board Member | 67 | 22-09-30 |
Richard Solomons
CHM | Chairman | 62 | 19-02-28 |
Andrew Ransom
CEO | Chief Executive Officer | 60 | 08-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.96% | 5 M€ | +7.05% | ||
0.84% | 11 M€ | +0.83% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 410.5 | -1.86% | 13,176,960 |
24-04-24 | 418.3 | -1.58% | 6,167,842 |
24-04-23 | 425 | -0.35% | 10,385,190 |
24-04-22 | 426.5 | +0.90% | 19,314,430 |
24-04-19 | 422.7 | +2.37% | 13,899,590 |
Delayed Quote London S.E., April 25, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RTO Stock